Cervicitis screening: Difference between revisions
Jump to navigation
Jump to search
m Template |
Prince Djan (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Cervicitis}} | {{Cervicitis}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} {{PTD}} | ||
==Overview== | ==Overview== | ||
==Screening== | ==Screening== | ||
Screening for the infectious causes of cervicitis is recommended. | |||
===Chlamydia cervicitis=== | |||
According to the 2015 Sexually Transmitted Diseases Treatment Guidelines by the CDC, screening for chlamydia is recommended as follows:<ref name=abc> Screening Recommendations Referenced in Treatment Guidelines and Original Recommendation Sources. CDC. http://www.cdc.gov/std/tg2015/screening-recommendations.htm. Accessed on January 6th, 2016</ref><ref name=cde> Screening recommendation for chlamydia. UPSTF. http://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/chlamydia-and-gonorrhea-screening?ds=1&s=chlamydia(2014). Acessed on September 8, 2016</ref> | |||
*Sexually active women under 25 years of age. | |||
*Sexually active women aged 25 years and older if at increased risk. | |||
*Retest approximately 3 months after treatment. | |||
==Pregnant Women== | |||
*All pregnant women under 25 years of age. | |||
*Pregnant women, aged 25 and older if at increased risk. | |||
*Retest during the 3rd trimester for women under 25 years of age or at risk. | |||
==Individuals with HIV== | |||
*For sexually active individuals, screen at first HIV evaluation, and at least annually thereafter. | |||
*More frequent screening might be appropriate depending on individual risk behaviors and the local epidemiology. | |||
===Gonococcal cervicitis=== | |||
Screening is recommendated in high risk people. | |||
===Other nongonococcal infections=== | |||
There is no specific screening modality. | |||
==References== | ==References== | ||
Revision as of 18:33, 20 September 2016
|
Cervicitis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Cervicitis screening On the Web |
|
American Roentgen Ray Society Images of Cervicitis screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Prince Tano Djan, BSc, MBChB [2]
Overview
Screening
Screening for the infectious causes of cervicitis is recommended.
Chlamydia cervicitis
According to the 2015 Sexually Transmitted Diseases Treatment Guidelines by the CDC, screening for chlamydia is recommended as follows:[1][2]
- Sexually active women under 25 years of age.
- Sexually active women aged 25 years and older if at increased risk.
- Retest approximately 3 months after treatment.
Pregnant Women
- All pregnant women under 25 years of age.
- Pregnant women, aged 25 and older if at increased risk.
- Retest during the 3rd trimester for women under 25 years of age or at risk.
Individuals with HIV
- For sexually active individuals, screen at first HIV evaluation, and at least annually thereafter.
- More frequent screening might be appropriate depending on individual risk behaviors and the local epidemiology.
Gonococcal cervicitis
Screening is recommendated in high risk people.
Other nongonococcal infections
There is no specific screening modality.
References
- ↑ Screening Recommendations Referenced in Treatment Guidelines and Original Recommendation Sources. CDC. http://www.cdc.gov/std/tg2015/screening-recommendations.htm. Accessed on January 6th, 2016
- ↑ Screening recommendation for chlamydia. UPSTF. http://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/chlamydia-and-gonorrhea-screening?ds=1&s=chlamydia(2014). Acessed on September 8, 2016